Search

everythinglearnresearchcommunity

for

Search:↓

A new taurine-based liquid can help treat hair loss by improving hair follicle health and promoting regrowth.

Dihydrotestosterone increases growth and spread of human brain cancer cells, and blocking its formation might help treat this cancer.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Retinoids might cause temporary hyperthyroidism in some patients.

New method accurately measures finasteride in medicine using NQS.

Lack of a certain enzyme causes hair to grey early by damaging stem cells, but an antioxidant can help prevent this.

Talquetamab may cause hair loss and skin issues.

ZSYY001 is safe, well-tolerated, and shows promise for treating advanced solid tumors.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

Alopecia triangular temporal is a rare condition with unclear causes and treatment, but trichoscopy helps in diagnosis.

New treatments for hair loss are being developed using molecular biology.

Systemic treatment is necessary for tinea capitis in children, with griseofulvin preferred for Microsporum infections.

Sacituzumab govitecan is effective but has side effects like hair loss and diarrhea in treating metastatic triple-negative breast cancer.

Applying thyroid hormones to the scalp can help hair grow.

Trichoriboside treatment helps maintain scalp hair by increasing cAMP levels in hair follicles of men with hair loss.

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

Pexidartinib often causes liver issues and fatigue, especially in women.

Thallium poisoning is highly toxic, causing severe health problems and can be fatal.

Nilotinib may cause gray hair to return to its original color.

Early detection and biotin treatment improve outcomes for biotinidase deficiency.

Overexpressing Tβ4 in cashmere goats improves hair fiber traits and increases cashmere yield.

Tacrolimus is a better option than cyclosporine due to fewer side effects.

Polygoni Cuspidati Rhizoma et Radix contains compounds that inhibit certain enzymes.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.